Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum

BACKGROUND: Cerebrospinal fluid (CSF) biomarkers are increasingly used in clinical practice for the diagnosis of Alzheimer's disease (AD). We aimed to 1) determine cutoff values of CSF biomarkers for AD, 2) investigate their clinical utility by estimating a concordance with amyloid positron emi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jongmin, Jang, Hyemin, Kang, Sung Hoon, Kim, Jaeho, Kim, Ji Sun, Kim, Jun Pyo, Kim, Hee Jin, Seo, Sang Won, Na, Duk L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669457/
https://www.ncbi.nlm.nih.gov/pubmed/33200589
http://dx.doi.org/10.3346/jkms.2020.35.e361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669457/
https://www.ncbi.nlm.nih.gov/pubmed/33200589
http://dx.doi.org/10.3346/jkms.2020.35.e361

Ejemplares similares